DRKS00011913
Completed
Not Applicable
Effect of antiviral therapy in patients with acute respiratory distress syndrome after CAP (community acquired pneumonia) and H1N1 infection on health-related quality of life (HRQoL) and cognitive performance - FUCHS
Charité Universitätsmedizin Berlin Klinik für Anästhesiologie m. S. Intensivmedizin Campus Benjamin Franklin0 sites42 target enrollmentApril 19, 2017
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- acute respiratory distress syndrome
- Sponsor
- Charité Universitätsmedizin Berlin Klinik für Anästhesiologie m. S. Intensivmedizin Campus Benjamin Franklin
- Enrollment
- 42
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •acute respiratory distress Syndrome (ARDS);
- •treatment period:
- •8/1/2009\-09/03/2011
Exclusion Criteria
- •(1\) no written informed consent
- •(2\) premorbid severe mental illness
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 4
Study to compare the effect of different antiviral medicines in COVID-19 infected sick childreHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/10/028234Dept of Pediatrics Medical College Kolkata
Completed
Not Applicable
Investigation of antiviral treatment for symptomatic congenital cytomegalovirus infectioCongenital cytomegalovirus infectionJPRN-UMIN000019464Department of Pediatrics, Nagoya University Graduate School of Medicine20
Not yet recruiting
Phase 3
Study of antiviral nutraceutical PICOVRID in COVID 19 patientsCTRI/2020/07/026534Indian Institute of Technology Bombay
Not yet recruiting
Not Applicable
Effect of direct-acting antiviral (DAA) drugs on HCV epidemiology among patients in public hospitals in southern Hessen, Germany.Patients' blood is tested for hepatitis C virus (HCV) antibodies. If the result is positive, the next step is to check for HCV RNA to detect an active infection.DRKS00028846Johann Wolfgang Goethe-Universität Frankfurt10,000
Active, not recruiting
Phase 1
Treatment of viral infections after stem cell Transplantation with specific immune cellschemo-refactory AdV, CMV and EBV infections after allogeneic stem cell transplantationTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2018-000853-29-ESKlinikum der Universität München149